Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France.

Emerging Infectious Diseases
Marie JaspardValerie Pourcher

Abstract

Linezolid is one of the most effective drugs for treating multidrug-resistant tuberculosis (MDR TB), but adverse effects remain problematic. We evaluated 57 MDR TB patients who had received >1 dose of linezolid during 2011-2016. Overall, patients received 600 mg/day of linezolid for a median of 13 months. In 33 (58%) patients, neurologic or ophthalmologic signs developed, and 18 (32%) had confirmed peripheral neuropathy, which for 78% was irreversible at 12 months after the end of TB treatment despite linezolid withdrawal. Among the 19 patients who underwent ophthalmologic evaluation, 14 patients had optic neuropathy that fully reversed for 2. A total of 16 (33%) of 49 patients had a linezolid trough concentration >2 mg/L, and among these, 14 (88%) experienced adverse effects. No significant association was found between trough concentration and neurologic toxicity. These findings suggest the need to closely monitor patients for neurologic signs and discuss optimal duration of linezolid treatment.

References

Oct 30, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Elsie LeeRobert Press
Oct 31, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hye-Ryoun KimJae-Joon Yim
Aug 9, 2008·The New England Journal of Medicine·Carole D MitnickMercedes C Becerra
Apr 2, 2010·The European Respiratory Journal·Z F UdwadiaG Moharil
May 6, 2010·American Journal of Respiratory and Critical Care Medicine·Armand Van DeunHans L Rieder
May 30, 2012·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·H-B XuH-P Xiao
Oct 19, 2012·The New England Journal of Medicine·Myungsun LeeClifton E Barry
Oct 4, 2013·Indian Journal of Ophthalmology·Divya KaruppannasamyDevisundaram Sundar
Apr 15, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gustavo E VelásquezSalmaan Keshavjee
May 31, 2014·Enfermedades infecciosas y microbiología clínica·Yemerisse Mauli Lalondriz BuenoFrancisco Santolaria
Sep 14, 2014·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·K J M AungH L Rieder
Sep 23, 2014·The European Respiratory Journal·Shenjie TangZhanjun Zhang
Oct 17, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lorenzo GuglielmettiUNKNOWN MDR-TB Management Group of the French National Reference Center for Mycobacteria and the Physicians of the French MDR-TB Coh
Jul 15, 2015·The European Respiratory Journal·Mathieu S BolhuisJan-Willem C Alffenaar
Jun 25, 2016·The European Respiratory Journal·Lorenzo GuglielmettiUNKNOWN MDR-TB Management Group of the French National Reference Center for Mycobacteria and the Physicians of the French MDR-TB Coh
Apr 24, 2018·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Sean P DempseyWilliam Scott Slagle
Mar 14, 2019·The New England Journal of Medicine·Andrew J NunnUNKNOWN STREAM Study Collaborators
Oct 20, 2019·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·L GuglielmettiN Veziris

❮ Previous
Next ❯

Citations

Nov 20, 2020·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·Ulrich KellnerGhazaleh Farmand
Oct 5, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marjorie Z ImperialRada M Savic

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Katsunori YanagiharaShigeru Kohno
Medical Journal, Armed Forces India
B B Naik
Neonatal Network : NN
Susan Givens Bell
© 2021 Meta ULC. All rights reserved